Login

British Drugmaker GlaxoSmithKline Trims US Office Space in Shift to Hybrid Work Model

Company Plans To Relocate Into Smaller Offices in Durham, North Carolina, and Philadelphia
British-based drugmaker GlaxoSmithKline is scaling back U.S. office space in a shift to a hybrid office model. (Getty Images)
British-based drugmaker GlaxoSmithKline is scaling back U.S. office space in a shift to a hybrid office model. (Getty Images)
CoStar News
October 5, 2021 | 7:25 P.M.

Global pharmaceutical giant GlaxoSmithKline is emptying another significant portion of its U.S. office real estate as it joins some other major U.S. employers in allowing employees to do some of their work from home.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE